Dr sahaeb the Dr ReddyI am still watching the script,
I means just watching, will watch it more to gain more experience.
RDY trade ideas
$RDY is Undervalued and Trending Up After Q4 Earnings DipDr Reddy's (NASDAQ: RDY) is an India-based pharma company that is one of the most dynamic companies in the industry. The company is up nearly +7% YTD, though share price dipped last week after the release of Q4/FY2023 financials due to base business growth lagging behind forecasts. However, I see this recent decrease as a prime window of opportunity to establish or augment a position in RDY given the broader picture their financials paint.
Though RDY's EPS slightly missed Zacks Consensus estimate by $0.01, FY2023 EPS was $3.30 compared to $1.72 the year prior, which indicates substantial YoY growth. Furthermore, revenue was up 15% compared to last year, evidencing a strong and growing cash flow for this global pharma giant. Even more promising was the 36% YoY growth Dr Reddys' saw in the category of North American generics, a region that constituted the plurality (40%) of net global sales. These robust growth figures were buoyed by record sales in FY2023 powered by numerous new product launches (including 12 news ANDAs with the US FDA) as RDY engages additional pharma verticals.
Likewise, cashflow and cash and hand remains strong, showing that this company has the underlying capital needed to continue funding R&D and global expansion efforts. RDY's fiscal picture for the entirety of FY2023 looks overall strong and very promising for the short and intermediate-term future.
Looking at the chart, one can clearly see the dip caused by some bearish sentiment after the release of financials on May 10th. However, both MACD and Momentum indicators are trending positive, suggesting a recovery in share price ahead. Meanwhile the stock maintains an average analyst PT of $61 for 10% upside from its current $55.30; given that share price had already exceeded this consensus estimate before the release of financials, this pullback can be viewed as a temporary recalibration that lays the groundwork for sustained gains moving forward.
RDY is a solid pharma midcap with a highly profitable bottom line, significant innovative capital, an ambitious R&D pipeline and a fast-expanding global footprint. Looking forward to see where things go from here, but for now I'm LT bullish on RDY.
Dr ReddyAs the script had a dramatic fall yesterday, now it seems to be a must watch for next few days.
As described in the chart drawing, I feel like immediate trading range is clear.
Dr Reddy Consolidation 1 year and breakoutHi everyone
lucrative opportunity created in drreddy
already creaated but I am late to post
Dr Reddy Idea for buyingHi buyers
dr reddy created best weekly breakout you can plan trade in 4 hour time frame rto reduce small Stop lose
enjoy profit
dr reddy short sellOverall in weekly and monthly it is bullish.
It's away from the moving averages.
It is suggesting a breakout which is a fakeout as it does not correlates with the moving averages.
the target should be 60% fib retracement which is 4520 appx.
then it should have a target of above 4700.
Let's se if it happens. if i can understand what i have learnt in all these years.
cheers,
Manu
DRREDDY - Weekly AnalysisIn the Weekly Chart of DRREDDY ,
we can see that, finally it has given a Breakout.
Let it retest and then enter with SL.
Dr Reddy Labs VCP PatternVolatility contraction pattern on dr reddy weekly charts,
Ascending triangle breakout
High Buying volumes
7% Tp 1
DRREDDY.... BULLISH. - Healthcare and Pharma SectorNSE:DRREDDY
This stock is fundamentally at ALL TIME HIGH but its PE at the lower band......
stock taking support of the major trendline (RED)
if it breaks 4615 level in WEEKLY TIMEFRAME with strong volume, then it can show a massive rally.
this is all for educational purpose, not a stock recommendation for trading.
invest at your own risk.
DR. REDDYS LABTHE IDEA WILL BE ONLY FOR STUDY PURPOSE .
wait for the breakout till then keep your eye on the stock .
DR REDDY Dr reddy
Up side Target 5335/4950
down side Target 3930/3385
Like, Share, Comment for regular updates.
Disclaimer
I am not sebi registered analyst My studies are Educational purpose only
Please consult with your Financial advisor before trading or investing
I may be 100% wrong as its my personal trade.
DRREDDY - Weekly AnalysisIn the Weekly Chart of DRREDDY ,
we can see that, it can now decide the trend and flow of it.
Lets see in which direction will it take the move.
DR Reddy PUT side successOur forecast was 3% move in Dr Reddy. We did not have a specific view but yes levels were provided. as said, we got our 3% move.
DR REDDYS LABSThis stock has created many resistance and two supports recently. A good sell below it's 1st support which is 4355.90 for target of 4298 and a good buy is above the resistance 4439.45 for a target price of 4504.1
Trade wisely, at your own risk appetite.
Good luck, Jai hind.
Range Break out in Dr Reddy LabsDouble Inside Candle formation in Dr Reddy Labs.
Break out should be caught well. May give a good RR trade.
Please consult your financial advisor before investing. This is for educational purpose only
DRREDDYDrreddy made ascending triangle pattern on 30 min TF & trying to trade above 4380( triangle breakout & multiple resistance zone) with decent volumes.
Could be bought with mentioned stoploss & target.
Trading in range good momentum possibleNSE:DRREDDY
trade on breakout side rectangle pattern breakout
DR REDDY LABHey traders This healthcare stock is making Ascending triangle pattern on Weekly timeframe chart
Resistance zone is 4615 (+-20) levels
Support zone is trendline
where strong support zone is 3650 zone.
#DRREDDY Weekly Major Support & Resistance Levels.Providing Weekly Support and Resistance levels for next coming week based on Central Pivot Range and its major support & resistance levels of week, where price can take support and face resistance. Three black lines indicating weekly Central Pivot Range. Previous week high & low also performs as a major support and resistance levels. Can take long & short positions according to how price perfoms at particular given support & resistance levels.
